Publications by authors named "R Sabatier"

Claim this Profile
D
Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.
P Harter, F Trillsch, A Okamoto, A Reuss, J-W Kim, R Sabatier

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kinetics and determinants of ESR1 mutation detection in metastatic breast cancer.
L Cabel, F Berger, T Bachelot, B Pistilli, F Dalenc, R Sabatier

Ann Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surgical approach and maintenance therapy in advanced low-grade serous ovarian cancer: Insights from the French ESME database.
Thomas Papazyan, Elodie Martin, Patricia Pautier, Catherine Guerin-Charbonnel, Elise Rowinski, Renaud Sabatier

Int J Gynecol Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BTN2A1 acquisition through trogocytosis enhances Vγ9Vδ2 T cell cytotoxicity against autologous and cancer cells.
Emilien Billon, Caroline Imbert, Damien Bruyat, Pierre Grassi, Lucie Robert, Renaud Sabatier

Cell Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune landscape and TAM density in endometrial cancer: implications for immune checkpoint inhibitors efficacy.
Olivia Le Saux, Renaud Sabatier, Isabelle Treilleux, Léa-Isabelle Renaud, Pierre-Emmanuel Brachet

Ther Adv Med Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis